A 48-year-old woman is found to have a salivary gland tumor on imaging. Which is the most common site of salivary gland tumors overall?

Explanation

## Most Common Site of Salivary Gland Tumors **Key Point:** The parotid gland is the most common site of salivary gland tumors, accounting for approximately 60–80% of all salivary gland neoplasms (both benign and malignant combined). **High-Yield:** The parotid gland contains the largest number of salivary acini and has the longest ductal system, which may explain the higher incidence of tumors at this site. ## Salivary Gland Tumor Distribution | Site | Frequency | Benign:Malignant Ratio | | --- | --- | --- | | Parotid | 60–80% | 4:1 (mostly benign) | | Submandibular | 10–15% | 1:1 (equal benign & malignant) | | Sublingual | 2–3% | 1:3 (mostly malignant) | | Minor salivary glands | 5–10% | 1:2 (mostly malignant) | **Clinical Pearl:** The **inverse relationship** between tumor frequency and malignancy rate is crucial: parotid tumors are common but mostly benign, while sublingual and minor salivary gland tumors are rare but more likely to be malignant. ## Why Parotid Tumors Are Most Common 1. **Largest gland** — parotid is the biggest salivary gland by mass 2. **Longest duct** — Stensen's duct is prone to obstruction and chronic irritation 3. **Highest acinar count** — more epithelial cells at risk for malignant transformation 4. **Longer observation period** — slow-growing benign tumors (pleomorphic adenoma) are often detected incidentally ## Most Common Parotid Tumor **Pleomorphic adenoma** (benign, 60% of parotid tumors) - Mixed tumor with epithelial and mesenchymal components - Slow-growing, painless, mobile - Risk of malignant transformation if untreated for >10 years **Mnemonic:** **PSMM** — Parotid tumors are Statistically Most Malignancy-free (mostly benign); Submandibular and Minor glands are More Malignant. **High-Yield:** When a patient presents with a salivary gland tumor, always consider the site: parotid tumors have a favorable prognosis (mostly benign), but tumors in the submandibular, sublingual, and minor salivary glands carry a higher risk of malignancy and warrant aggressive investigation and treatment.